Ventyx raises $100M in private placement; discloses securities class action lawsuit

Ventyx Biosciences, Inc.

Sold 11,174,000 shares at $8.95/share for gross proceeds ~$100M; led by Farallon, Cormorant, Deerfield, Redmile, Surveyor.
Net proceeds to fund VTX3232, VTX2735, VTX002 clinical development and preclinical programs; cash runway extended into at least 2H 2026.
Private placement expected to close on March 11, 2024, subject to customary conditions.
Securities class action filed Mar 1 alleges misleading statements on VTX958 Phase 2 trial; company believes lawsuit without merit.

item 1.01 item 3.02 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Ventyx Biosciences, Inc. entered into Registration Rights Agreement with the Purchasers (effective 2024-03-06).

Action: entry
Agreement: equity purchase
Counterparty: the Purchasers
Effective: 2024-03-06

Exact text from the filing

In connection with the Private Placement, the Company and the Purchasers entered into a Registration Rights Agreement, dated March 6, 2024 (the “ Registration Rights Agreement ”), providing for the registration for resale of the Shares that are not then registered on an effective registration statement

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Ventyx Biosciences, Inc. entered into Stock Purchase Agreement with certain qualified institutional buyers and institutional accredited investors valued at approximately $100.0 million (effective 2024-03-06).

Action: entry
Agreement: equity purchase
Counterparty: certain qualified institutional buyers and institutional accredited investors
Value: approximately $100.0 million
Effective: 2024-03-06

Exact text from the filing

On March 6, 2024, Ventyx Biosciences, Inc. (the “ Company ”) entered into a Stock Purchase Agreement (the “ Purchase Agreement ”) for a private placement (the “ Private Placement ”) with certain qualified institutional buyers and institutional accredited investors (each, a “ Purchaser ” and collectively, the “ Purchasers ”).

View on SEC.gov

589 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0001193125-24-061538

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.